Page 153 - Cardiac Nursing

8:2
009
M
5 A
0
9/0
31.
qxd
29
e 1
ara
Apt
g
P
1-1
p11
K34
0-c
05_
9/2
LWB
LWB K34 0-c 05_ p11 1-1 31. qxd 0 9/0 9/2 009 0 0 8:2 5 A M P a a g e 1 29 Apt ara
LWBK340-c05_p111-131.qxd 09/09/2009 08:25 AM Page 129 Aptara
C HAPTER 5 / Atherosclerosis, Inflammation, and Acute Coronary Syndrome 129
128. Blann, A. D., & McCollum, C. N. (1994). Circulating endothelial termittent claudication, coronary heart disease, and family history: The
cell/leukocyte adhesion molecules in atherosclerosis. Thrombosis and Scottish Heart Health Study. British Heart Journal, 69, 338–342.
Haemostasis, 72, 151–154. 151. Ma, J., Hennekens, C. H., Ridker, P. M., et al. (1999). A prospective study
129. Fukumoto, Y., Shimokawa, H., Ito, A., et al. (1997). Inflammatory cy- of fibrinogen and risk of myocardial infarction in the Physicians’ Health
tokines cause coronary arteriosclerosis-like changes and alterations in the Study. Journal of the American College of Cardiology, 33, 1347–1352.
smooth-muscle phenotypes in pigs. Journal of Cardiovascular Pharma- 152. Maresca, G., Di Blasio, A., Marchioli, R., et al. (1999). Measuring
cology, 29, 222–231. plasma fibrinogen to predict stroke and myocardial infarction: An up-
130. Pober, J. S., Bevilacqua, M. P., Mendrick, D. L., et al. (1986). Two dis- date. Arteriosclerosis, Thrombosis, and Vascular Biology, 19, 1368–1377.
tinct monokines, interleukin 1 and tumor necrosis factor, each inde- 153. Sato, S., Nakamura, M., Iida, M., et al. (2000). Plasma fibrinogen and
pendently induce biosynthesis and transient expression of the same anti- coronary heart disease in urban Japanese. American Journal of Epidemi-
gen on the surface of cultured human vascular endothelial cells. Journal ology, 152, 420–423.
6
6
of Immunology, 136, 1680–1687. 154. Tracy, R. P., Arnold, A. M., Ettinger, W., et al. (1999). The relationship
131. Cybulsky, M. I., Iiyama, K., Li, H., et al. (2001). A major role for of fibrinogen and factors VII and VIII to incident cardiovascular disease
VCAM-1, but not ICAM-1, in early atherosclerosis. Journal of Clinical and death in the elderly: Results from the cardiovascular health study.
7
7
Investigations, 107, 1255–1262. Arteriosclerosis, Thrombosis, and Vascular Biology, 19, 1776–1783.
T
T
132. Davies, M. J., Richardson, P. D., Woolf, N., et al. (1993). Risk of throm- 155. Tracy, R. P., Bovill, E. G., Yanez, D., et al. (1995). Fibrinogen and factor
bosis in human atherosclerotic plaques: Role of extracellular lipid, VIII, but not factor VII, are associated with measures of subclinical car-
macrophage, and smooth muscle cell content. British Heart Journal, 69, diovascular disease in the elderly. Results from The Cardiovascular Health
377–381. Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 15, 1269–1279.
5
133. Li, H., Cybulsky, M. I., Gimbrone, M. A., Jr., et al. (1993). Inducible 156. Folsom, A. R., Rosamond, W. D., Shahar, E., et al. (1999). Prospective
expression of vascular cell adhesion molecule-1 by vascular smooth mus- study of markers of hemostatic function with risk of ischemic stroke.
cle cells in vitro and within rabbit atheroma. American Journal of Pathol- The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
ogy, 143, 1551–1559. Circulation, 100, 736–742.
134. Haught, W. H., Mansour, M., Rothlein, R., et al. (1996). Alterations in 157. Smith, F. B., Lee, A. J., Fowkes, F. G., et al. (1997). Hemostatic factors as
circulating intercellular adhesion molecule-1 and L-selectin: Further ev- predictors of ischemic heart disease and stroke in the Edinburgh Artery
7
idence for chronic inflammation in ischemic heart disease. American Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 3321–3325.
7
Heart Journal, 132, 1–8. 158. Genest, J., Jr., & Cohn, J. S. (1995). Clustering of cardiovascular risk
135. Hwang, S. J., Ballantyne, C. M., Sharrett, A. R., et al. (1997). Circulat- factors: Targeting high-risk individuals. American Journal of Cardiology,
ing adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid 76, 8A–20A.
6
6
atherosclerosis and incident coronary heart disease cases: The Athero- 159. Muldoon, M. F., Herbert, T. B., Patterson, S. M., et al. (1995). Effects
6
sclerosis Risk In Communities (ARIC) study. Circulation, 96, of acute psychological stress on serum lipid levels, hemoconcentration,
6
4219–4225. and blood viscosity. Archives of Internal Medicine, 155, 615–620.
136. Ridker, P. M. (1998). C-reactive protein and risks of future myocardial 160. Pepys, M. (1995). The acute phase response and c-reactive protein. Ox-
infarction and thrombotic stroke. European Heart Journal, 19, 1–3. ford Textbook of Medicine. Oxford, UK: Oxford University Press.
137. Blankenberg, S., Rupprecht, H. J., Bickel, C., et al. (2001). Circulating 161. Ridker, P. M., Cushman, M., Stampfer, M. J., et al. (1997). Inflamma-
cell adhesion molecules and death in patients with coronary artery dis- tion, aspirin, and the risk of cardiovascular disease in apparently healthy
4
6
6
ease. Circulation, 104, 1336–1342. men. New England Journal of Medicine, 336, 973–979.
4
138. Miller, M. A., Sagnella, G. A., Kerry, S. M., et al. (2003). Ethnic differ- 162. Ridker, P. M., Cushman, M., Stampfer, M. J., et al. (1998). Plasma con-
ences in circulating soluble adhesion molecules: The Wandsworth Heart centration of C-reactive protein and risk of developing peripheral vascu-
4
4
and Stroke Study. Clinical Science (London), 104, 591–598. lar disease. Circulation, 97, 425–428.
7
7
139. Lefkovits, J., Plow, E. F., & Topol, E. J. (1995). Platelet glycoprotein 163. Ridker, P. M., Rifai, N., Clearfield, M., et al. (2001). Measurement of
IIb/IIIa receptors in cardiovascular medicine. New England Journal of C-reactive protein for the targeting of statin therapy in the primary pre-
Medicine, 332, 1553–1559. vention of acute coronary events. New England Journal of Medicine, 344,
4
4
140. Lefkovits, J., & Topol, E. J. (1995). Platelet glycoprotein IIb/IIIa recep- 1959–1965.
tor inhibitors in ischemic heart disease. Current Opinion in Cardiology, 164. Kuller, L. H., Tracy, R. P., Shaten, J., et al. (1996). Relation of C-reac-
10, 420–426. tive protein and coronary heart disease in the MRFIT nested case-con-
141. Ernst, E., & Resch, K. L. (1993). Fibrinogen as a cardiovascular risk fac- trol study. Multiple Risk Factor Intervention Trial. American Journal of
tor: A meta-analysis and review of the literature. Annals of Internal Med- Epidemiology, 144, 537–547.
4
4
icine, 118, 956–963. 165. Tracy, R. P., Lemaitre, R. N., Psaty, B. M., et al. (1997). Relationship
142. Meade, T. W., Mellows, S., Brozovic, M., et al. (1986). Haemostatic of C-reactive protein to risk of cardiovascular disease in the elderly.
function and ischaemic heart disease: Principal results of the Northwick Results from the Cardiovascular Health Study and the Rural Health
Park Heart Study. Lancet, 2, 533–537. Promotion Project. Arteriosclerosis, Thrombosis, and Vascular Biology, 17,
143. Eber, B., & Schumacher, M. (1993). Fibrinogen: Its role in the hemo- 1121–1127.
static regulation in atherosclerosis. Seminars in Thrombosis and Hemosta- 166. Ridker, P. M., Buring, J. E., Shih, J., et al. (1998). Prospective study of
sis, 19, 104–107. C-reactive protein and the risk of future cardiovascular events among
144. Smith, E. B. (1986). Fibrinogen, fibrin and fibrin degradation products apparently healthy women. Circulation, 98, 731–733.
in relation to atherosclerosis. Clinical Haematology, 15, 355–370. 167. Koenig, W., Sund, M., Frohlich, M., et al. (1999). C-Reactive protein,
145. Smith, E. B., Keen, G. A., Grant, A., et al. (1990). Fate of fibrinogen in a sensitive marker of inflammation, predicts future risk of coronary heart
human arterial intima. Arteriosclerosis, 10, 263–275. disease in initially healthy middle-aged men: Results from the MON-
146. Thompson, W. D., & Smith, E. B. (1989). Atherosclerosis and the co- ICA (Monitoring Trends and Determinants in Cardiovascular Disease)
agulation system. Journal of Pathology, 159, 97–106. Augsburg Cohort Study, 1984 to 1992. Circulation, 99, 237–242.
147. Miyao, Y., Yasue, H., Ogawa, H., et al. (1993). Elevated plasma inter- 168. Roivainen, M., Viik-Kajander, M., Palosuo, T., et al. (2000). Infections,
leukin-6 levels in patients with acute myocardial infarction. American inflammation, and the risk of coronary heart disease. Circulation, 101,
6
6
Heart Journal, 126, 1299–1304. 252–257.
148. Danesh, J., Collins, R., Appleby P., et al. (1998). Association of fibrino- 169. Ridker, P. M., Hennekens, C. H., Buring, J. E., et al. (2000). C-reactive
gen, C-reactive protein, albumin, or leukocyte count with coronary protein and other markers of inflammation in the prediction of cardiovas-
heart disease: Meta-analyses of prospective studies. Journal of the Ameri- cular disease in women. New England Journal of Medicine, 342, 836–843.
can Medical Association, 279, 1477–1482. 170. Biasucci, L. M., Liuzzo, G., Buffon, A., et al. (1999). The variable role
149. Folsom, A. R., Aleksic, N., Ahn, C., et al. (2001). Beta-fibrinogen gene- of inflammation in acute coronary syndromes and in restenosis. Semi-
455G/A polymorphism and coronary heart disease incidence: The Ath- nars in Interventional Cardiology, 4, 105–110.
4
4
erosclerosis Risk in Communities (ARIC) Study. Annals of Epidemiology, 171. de Winter, R. J., Bholasingh, R., Lijmer, J. G., et al. (1999). Indepen-
11, 166–170. dent prognostic value of C-reactive protein and troponin I in patients
150. Lee, A. J., Lowe, G. D., Woodward, M., et al. (1993). Fibrinogen in re- with unstable angina or non-Q-wave myocardial infarction. Cardiovas-
lation to personal history of prevalent hypertension, diabetes, stroke, in- cular Research, 42, 240–245.